-
-
1 × $2,184.00 -
1 × $607.00 -
1 × $712.00 -
1 × $446.00 -
1 × $554.00 -
1 × $573.00 -
1 × $520.00 -
1 × $2,190.00 -
-
-
1 × $1,091.00
-
1 × $579.00
-
1 × $1,068.00 -
1 × $2,810.00 -
-
1 × $680.00
-
1 × $1,340.00 -
2 × $2,223.00 -
-
-
-
1 × $1,018.00 -
2 × $819.00 -
-
1 × $6,360.00 -
1 × $657.00 -
-
1 × $2,219.00 -
-
2 × $403.00
-
1 × $1,585.00 -
-
1 × $1,511.00 -
2 × $2,492.00 -
-
1 × $616.00 -
-
1 × $613.00
-
1 × $951.00 -
1 × $25,527.00 -
-
1 × $706.00 -
-
-
1 × $471.00 -
2 × $740.00 -
-
1 × $537.00 -
-
1 × $1,068.00 -
1 × $1,752.00 -
1 × $1,970.00 -
-
1 × $1,191.00
-
1 × $1,185.00 -
1 × $412.00 -
-
1 × $894.00 -
1 × $1,640.00 -
1 × $3,723.00 -
2 × $1,092.00 -
1 × $521.00
-
-
1 × $656.00 -
1 × $673.00
-
-
1 × $570.00 -
-
-
-
-
1 × $1,311.00 -
1 × $2,302.00 -
-
-
-
1 × $2,390.00 -
1 × $3,417.00 -
1 × $2,834.00 -
-
-
2 × $2,436.00 -
-
1 × $4,667.00 -
1 × $1,377.00 -
1 × $1,034.00 -
-
-
1 × $587.00 -
-
-
-
-
1 × $5,861.00 -
1 × $521.00
-
1 × $1,106.00 -
-
1 × $2,361.00 -
1 × $7,433.00 -
2 × $1,406.00 -
-
1 × $642.00 -
1 × $524.00 -
-
-
1 × $484.00 -
-
-
1 × $1,824.00 -
1 × $3,416.00 -
1 × $2,164.00
Roll over image to zoom in
This item can only ship to a medical or educational facility.
The new wireless BD Veritor™ Plus System gives health care providers and laboratorians in physician offices, clinics, hospitals and Integrated Delivery Networks (IDNs) with objective, lab-quality immunoassay test results within minutes. This fast and accurate solution streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. The new system can help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV), COVID-19 (SARS-2-COV) and group A strep while the patient is still on site, which can enable faster decision making for an earlier intervention opportunity.
Features and Benefits
- Faster access to test results: Help inform appropriate and targeted treatment decisions.
- Improved Workflow: The BD Veritor™ Plus Analyzer improves workflow with an Analyze Now or Walk Away mode, providing test results (with a printenabled function) and aiding in decision making while the patient is onsite.
- Improved Traceability: The optional BD Veritor™ InfoScan module can scan 3 different identifiers (operator ID, specimen ID and test kit /lot) that can be locally recorded, printed or downloaded, and reduces hands-on time through automated documentation
- Modularity: Provides a unique solution to meet each testing site’s preference
- Advanced particle technology: Enhances sensitivity by using a proprietary process to produce highly stable, modified colloidal metal particles.
- Adaptive read technology: Compensates for background and non-specific binding helps improve specificity to reduce false-positive results
- BD Veritor SARS-CoV-2 & Flu A+B Rapid Detection Kit (Included): The BD Veritor System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.
Materials Included
- BD Veritor™ Plus System Anaylzer
- 2 AA Batteries
- 2 SARS-CoV-2 & Influenza A + B Rapid Detection Kit (30 Tests/Kits)
- User manual
CPT Code
- 87804-QW: Infectious agent antigen detection by immunoassay with direct optical observation, influenza A
- National Average Reimbursement: $16.00
- 878704-59: Infectious agent antigen detection by immunoassay with direct optical observation, influenza B
- National Average Reimbursement: $16.00
- 87426 – Infectious agent antigen detection by immunoassay technique (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative, multiple-step method, severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV-2 [COVID-19])
